KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.
Rahul Gupta, N Director, Office of National Drug Control Policy, Office of National Drug Control Policy, disclosed 8 transactions
· Executive-branch trades · U.S. Office of Government Ethics (Form 278-T)
2022-12-01 · sale
Kimberly-Clark Corp. — $1,001 - $15,000
2022-11-23 · sale
Kimberly-Clark Corp. — $1,001 - $15,000
2022-11-23 · sale
NIKE, Inc. — $1,001 - $15,000
2022-11-22 · sale
Kimberly-Clark Corp. — $1,001 - $15,000
2022-11-08 · sale
General Electric Co. — $1,001 - $15,000
2022-10-28 · purchase
Amazon.com, Inc. — $1,001 - $15,000
2022-10-28 · sale
Kimberly-Clark Corp. — $1,001 - $15,000
2022-10-27 · sale
Kimberly-Clark Corp. — $1,001 - $15,000
The complete record
Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.
